We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
-15.67%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$4.98B
AUM Growth
-$1.04B
Cap. Flow
+$50.1M
Cap. Flow %
1.01%
Top 10 Hldgs %
30.66%
Holding
1,260
New
93
Increased
866
Reduced
230
Closed
68

Top Buys

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$40.1M
2
PG icon
Procter & Gamble
PG
+$19.2M
3
MRK icon
Merck
MRK
+$12.2M
4
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$10.3M
5
IBM icon
IBM
IBM
+$9.7M

Top Sells

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$37.9M
2
AAPL icon
Apple
AAPL
+$19.7M
3
MSFT icon
Microsoft
MSFT
+$14.9M
4
HD icon
Home Depot
HD
+$14.7M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$8.67M

Sector Composition

Rank Sector Weight
1 Technology 29.34%
2 Healthcare 13.95%
3 Consumer Discretionary 12.19%
4 Financials 10.87%
5 Communication Services 8.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DHC
1176
Diversified Healthcare Trust
DHC
$1.9B
$23K ﹤0.01%
12,845
+1,553
+14% +$3.55K
BNGO icon
1177
Bionano Genomics
BNGO
$14.3M
$22K ﹤0.01%
26
+3
+13% +$3.09K
NAT icon
1178
Nordic American Tanker
NAT
$1.43B
$22K ﹤0.01%
+10,314
New +$24.6K
CCO icon
1179
Clear Channel Outdoor Holdings
CCO
$1.22B
$21K ﹤0.01%
19,769
+2,526
+15% +$5.29K
INO icon
1180
Inovio Pharmaceuticals
INO
$130M
$21K ﹤0.01%
+989
New +$27.9K
ADMA icon
1181
ADMA Biologics
ADMA
$2.12B
$20K ﹤0.01%
+10,082
New +$19.8K
FIRY
1182
Firy Inc
FIRY
$167M
$20K ﹤0.01%
822
-1,021
-55% -$39.8K
NEUE
1183
DELISTED
NeueHealth
NEUE
$19K ﹤0.01%
129
-24
-16% -$3.49K
AMRS
1184
DELISTED
Amyris Inc.
AMRS
$19K ﹤0.01%
+10,534
New +$31K
CORZ
1185
DELISTED
Core Scientific, Inc. Common Stock
CORZ
$18K ﹤0.01%
+11,780
New +$54.1K
HIPO icon
1186
Hippo Holdings
HIPO
$861M
$12K ﹤0.01%
+553
New +$20.4K
URG
1187
Ur-Energy
URG
$609M
$12K ﹤0.01%
+11,444
New +$15.3K
VLDR
1188
DELISTED
Velodyne Lidar, Inc. Common Stock
VLDR
$10K ﹤0.01%
+10,470
New +$18.1K
VTGN icon
1189
VistaGen Therapeutics
VTGN
$11.4M
$9K ﹤0.01%
+352
New +$12.4K
VBIV
1190
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
$8K ﹤0.01%
+345
New +$11.7K
ENDP
1191
DELISTED
Endo International plc
ENDP
$6K ﹤0.01%
12,613
+1,730
+16% +$2.2K
ADPT icon
1192
Adaptive Biotechnologies
ADPT
$4.22B
-11,412
Closed -$158K
AMC icon
1193
AMC Entertainment Holdings
AMC
$2.41B
-2,504
Closed -$617K
APPS icon
1194
Digital Turbine
APPS
$1.38B
-13,138
Closed -$576K
OPTU
1195
Optimum Communications Inc
OPTU
$389M
-17,258
Closed -$215K
BEPC icon
1196
Brookfield Renewable
BEPC
$6.12B
-4,856
Closed -$213K
BYND icon
1197
Beyond Meat
BYND
$241M
-188
Closed -$273K
CARG icon
1198
CarGurus
CARG
$3.24B
-5,051
Closed -$214K
CHGG icon
1199
Chegg
CHGG
$89M
-12,453
Closed -$452K
CNMD icon
1200
CONMED
CNMD
$1.51B
-1,844
Closed -$273K

Similar funds

Xponance's Q2 2022 Portfolio in Review

As of Q2 2022, Xponance held 1,260 positions worth $4.98B, down 17% from $6.01B the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Xponance's Q2 2022 filing shows 93 new, 866 increased, 230 reduced and 68 closed positions. Its largest new stake was Warner Bros: 370,598 shares worth $4.97M. The largest sale was Meta Platforms (Facebook), an estimated $37.9M.

By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.

  • Xponance's largest Q2 2022 buy was Warner Bros: 370,598 shares worth $4.97M.
  • Xponance added most to UnitedHealth in Q2 2022, an estimated $40.1M increase.
  • Xponance's biggest Q2 2022 reduction was Meta Platforms (Facebook), cutting an estimated $37.9M.
  • Xponance fully exited ASPEN TECHNOLOGY INC in Q2 2022, selling an estimated $2.36M.
  • Xponance's ten largest holdings make up 31% of its $4.98B portfolio in Q2 2022.
  • Xponance opened 93 new positions and closed 68 in Q2 2022.
  • Xponance's portfolio value fell 17% quarter-over-quarter to $4.98B.

Based on Xponance's 13F filing for Q2 2022, filed 2 Aug 2022.